TIAA CREF Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $24.6M | Sell |
206,490
-70,134
| -25% | -$8.36M | 0.02% | 628 |
|
|
2018
Q4 | $30.2M | Sell |
276,624
-5,266
| -2% | -$575K | 0.02% | 518 |
|
|
2018
Q3 | $45.5M | Buy |
281,890
+73,792
| +35% | +$11.9M | 0.03% | 469 |
|
|
2018
Q2 | $27.5M | Buy |
208,098
+5,962
| +3% | +$788K | 0.02% | 618 |
|
|
2018
Q1 | $15M | Buy |
202,136
+9,040
| +5% | +$670K | 0.01% | 893 |
|
|
2017
Q4 | $10.7M | Sell |
193,096
-7,996
| -4% | -$445K | 0.01% | 1098 |
|
|
2017
Q3 | $9.12M | Buy |
201,092
+35,003
| +21% | +$1.59M | 0.01% | 1213 |
|
|
2017
Q2 | $5.6M | Sell |
166,089
-33,913
| -17% | -$1.14M | ﹤0.01% | 1523 |
|
|
2017
Q1 | $5.92M | Sell |
200,002
-13,244
| -6% | -$392K | ﹤0.01% | 1484 |
|
|
2016
Q4 | $5.85M | Sell |
213,246
-37,214
| -15% | -$1.02M | ﹤0.01% | 1495 |
|
|
2016
Q3 | $15.4K | Sell |
250,460
-8,422
| -3% | -$517 | 0.01% | 883 |
|
|
2016
Q2 | $4.94M | Buy |
258,882
+42,175
| +19% | +$804K | ﹤0.01% | 1543 |
|
|
2016
Q1 | $4.23M | Buy |
216,707
+11,334
| +6% | +$221K | ﹤0.01% | 1611 |
|
|
2015
Q4 | $7.92M | Buy |
205,373
+7,540
| +4% | +$291K | 0.01% | 1217 |
|
|
2015
Q3 | $6.35M | Buy |
197,833
+225
| +0.1% | +$7.22K | 0.01% | 1377 |
|
|
2015
Q2 | $6.01M | Sell |
197,608
-67,611
| -25% | -$2.06M | ﹤0.01% | 1541 |
|
|
2015
Q1 | $3.52M | Buy |
265,219
+634
| +0.2% | +$8.42K | ﹤0.01% | 1867 |
|
|
2014
Q4 | $3.83M | Sell |
264,585
-7,230
| -3% | -$105K | ﹤0.01% | 1819 |
|
|
2014
Q3 | $5.74M | Sell |
271,815
-3,782
| -1% | -$79.8K | ﹤0.01% | 1506 |
|
|
2014
Q2 | $8.21M | Buy |
275,597
+7,316
| +3% | +$218K | 0.01% | 1313 |
|
|
2014
Q1 | $6.45M | Buy |
268,281
+59,539
| +29% | +$1.43M | ﹤0.01% | 1432 |
|
|
2013
Q4 | $4.25M | Buy |
208,742
+55,839
| +37% | +$1.14M | ﹤0.01% | 1756 |
|
|
2013
Q3 | $7.22M | Buy |
152,903
+24,389
| +19% | +$1.15M | 0.01% | 1312 |
|
|
2013
Q2 | $4.89M | Buy |
+128,514
| New | +$4.89M | ﹤0.01% | 1540 |
|